Protection in a mouse peritonitis model mediated by iron-regulated outer-membrane protein of Salmonella typhi coupled to its Vi antigen

Journal of Medical Microbiology

Volumn 53, Issue 7, 2004, Pages 705-709

  Chibber, Sanjay ^a   Bhardwaj, Sonia B ^a,b  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IRON REGULATED OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PERITONITIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EDEMA; FOOT PAD; LIVER; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PEYER PATCH; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ISOLATION; SALMONELLA TYPHI; SALMONELLOSIS; SPLEEN; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY, DELAYED; LIVER; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; PERITONITIS; PEYER'S PATCHES; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; SALMONELLA TYPHI; SALMONELLA VACCINES; SPLEEN; TYPHOID FEVER; VACCINATION; VACCINES, CONJUGATE;

EID: 3142727597     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05378-0     Document Type: Article

References (23)

1. Acharya, I. L., Lowe, C. U., Thapa, R., Gurubacharya, V. L., Shrestha, M. B., Cadoz, M., Schulz, D., Armand, J., Bryla, D. A., Trollfors, B. & other authors (1987). Prevention of typhoid fever in Nepal with Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 317, 1101-1104.
2. Allen, P. M., Fisher, D., Saunders, J. R. & Hart, C. A. (1987). The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing. J Med Microbiol 24, 363-370.
3. Banerjee-Bhatnagar, N. & Frasch, C. E. (1990). Expression of Neisseria meningitidis iron-regulated outer membrane proteins including a 70-kilodalton transferrin receptor, and their potential for use as vaccines. Infect Immun 58, 2875-2881.
4. Beuvery, E. C., van Rossum, F. & Nagel, J. (1982). Comparison of the induction of immunoglobulins M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharides and their protein conjugates. Infect Immun 37, 15-22.
5. Cadoz, M. (1998). Potential and limitations of polysaccharide vaccines in infancy. Vaccine 16, 1391-1395.
6. Chibber, S. & Bajaj, J. (1995). Polysaccharide-iron-regulated cell surface protein conjugate vaccine its role in protection against Klebsiella pneumoniae-mduced lobar pneumonia. Vaccine 13, 179-184.
7. Desiderio, J. V. & Campbell, S. G. (1985). Immunization against experimental murine salmonellosis with liposome-associated O-antigen. Infect Immun 48, 658-663.
8. Filip, C., Fletcher, G., Wulff, J. L. & Earhart, C. F. (1973). Solubilization of cytoplasmic membrane of Escherichia coli by ionic detergent sodium-lauryl sarcosinate. J Bacteriol 115, 717-772.
9. Frantz, I. D. (1942). Growth requirements of the meningococcus. J Bacteriol 43, 757-761.
10. Gotschlich, E. C. (1975). Development of polysaccharide vaccines for the prevention of meningococcal diseases. Monogr Allergy 9, 245-258.
11. Guerinot, M. L. (1994). Microbial iron transport. Annu Rev Microbiol 48, 743-772.
12. Kossaczka, Z., Lin, F. Y., Ho, V. A. & 11 other authors (1999). Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year old children in Vietnam. Infect Immun 67, 5806-5810.
13. Kussi, N., Nurminen, M., Saxen, H., Valtonen, M. & Makela, P. H. (1979). Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun 25, 857-862.
14. Laemmli, U. K. (1970). Cleavage of structural properties during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
15. Lin, F. Y., Ho, V. A., Khiem, H. B. & 9 other authors (2001). The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344, 1263-1269.
16. Lucier, T. S., Fetherston, J. D., Brubaker, R. R. & Perry, R. D. (1996). Iron uptake and iron-repressible polypeptides in Yersinia pestis. Infect Immun 64, 3023-3031.
17. Paniagua, J., Garcia, J. A., Lopez, C. R., Gonzalez, C. R., Isibasi, A. & Kumate, J. (1992). Conjugate vaccines against bacterial infections: typhoid fever. Salud Publica Mex 34, 268-273 (in Spanish).
18. Reissbrodt, R., Kingsley, R., Rabsch W., Beer, W., Roberts, M. & Williams, P. H. (1997). Iron regulated excretion of acids by S. typhimurium. J Bacteriol 179, 4538-4544.
19. Robbins, J. B. & Schneerson, R. (1990). Polysaccharide-protein conjugates: a new generation of vaccines. J Infect Dis 161, 821-832.
20. Singh, M., Ganguly, N. K., Kumar, L. & Vohra, H. (1999). Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi. Microbiol Immunol 43, 535-542.
21. Szu, S. C., Taylor, D. N., Trofa, A. C., Clements, J. D., Shiloach, J., Sadoff, J. C., Bryla, D. A. & Robbins, J. B. (1994). Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect Immun 62, 4440-4444.
22. Williams, P., Lambert, P. A., Brown, M. K. W. & James, R. J. (1983). Role of the O and R antigen in determining antimicrobial agents. Chemotherapy 31, 7562-7585.
23. Yang, H. H., Wu, C. G., Xie, G. Z. & 17 other authors (2001). Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ 79, 625-631.